---
title: "Kymera, with new data, takes early step toward a Dupixent-like pill"
date: Mon, 02 Jun 2025 17:56:00 -0400
source: "BioPharmaDive"
link: "https://www.biopharmadive.com/news/kymera-phase-1-study-results-stat6-protein-degrader/749579/"
---

<p>Phase 1 results disclosed Monday indicate the company&rsquo;s protein-degrading drug can affect a tough-to-reach target called STAT6 that&rsquo;s implicated in many autoimmune conditions. &nbsp;</p>